XERIS BIOPHARMA HOLDINGS INC

Check Xeris Biopharma’s latest trade: USD 10.20, up 23.6% YTD, above its 200‑day MA yet down 3.05% intraday—find key metrics & market context now.

Explore why Xeris Biopharma (XERS) remains a bullish biotech pick, with solid 200‑day support, a 23.6% rally, and a unique liquid‑stable injection platform driving growth.

Watch Xeris Biopharma (XERS) surge 26.48% YTD—current share price $10.78, $2B cap, and 200‑day SMA $7.38. Dive into today’s market outlook.